{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3CL-Pro", "SARS-CoV-2", "antivirals", "binding space", "consensus models", "docking simulations", "drug repurposing", "isomeric space", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33557115", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "04"}], "Language": ["eng"], "ELocationID": ["797", "10.3390/molecules26040797"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "04"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.", "Abstract": {"AbstractText": ["The 3CL-Protease appears to be a very promising medicinal target to develop anti-SARS-CoV-2 agents. The availability of resolved structures allows structure-based computational approaches to be carried out even though the lack of known inhibitors prevents a proper validation of the performed simulations. The innovative idea of the study is to exploit known inhibitors of SARS-CoV 3CL-Pro as a training set to perform and validate multiple virtual screening campaigns. Docking simulations using four different programs (Fred, Glide, LiGen, and PLANTS) were performed investigating the role of both multiple binding modes (by binding space) and multiple isomers/states (by developing the corresponding isomeric space). The computed docking scores were used to develop consensus models, which allow an in-depth comparison of the resulting performances. On average, the reached performances revealed the different sensitivity to isomeric differences and multiple binding modes between the four docking engines. In detail, Glide and LiGen are the tools that best benefit from isomeric and binding space, respectively, while Fred is the most insensitive program. The obtained results emphasize the fruitful role of combining various docking tools to optimize the predictive performances. Taken together, the performed simulations allowed the rational development of highly performing virtual screening workflows, which could be further optimized by considering different 3CL-Pro structures and, more importantly, by including true SARS-CoV-2 3CL-Pro inhibitors (as learning set) when available."]}, "AuthorList": [{"Identifier": ["0000-0002-9175-243X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Domp\u00e9 Farmaceutici SpA, Via Campo di Pile, 67100 L'Aquila, Italy."}], "LastName": "Manelfi", "ForeName": "Candida", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biomedicine, Institute for Neuroscience and Medicine (INM-9) and Institute for Advanced Simulations (IAS-5), Forschungszentrum J\u00fclich, 52425 J\u00fclich, Germany."}, {"Identifier": [], "Affiliation": "Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen, 52062 Aachen, Germany."}], "LastName": "Gossen", "ForeName": "Jonas", "Initials": "J"}, {"Identifier": ["0000-0002-5731-3396"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, Via Mangiagalli, 25, I-20133 Milano, Italy."}], "LastName": "Gervasoni", "ForeName": "Silvia", "Initials": "S"}, {"Identifier": ["0000-0003-4789-0955"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Domp\u00e9 Farmaceutici SpA, Via Campo di Pile, 67100 L'Aquila, Italy."}], "LastName": "Talarico", "ForeName": "Carmine", "Initials": "C"}, {"Identifier": ["0000-0002-3560-4539"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biomedicine, Institute for Neuroscience and Medicine (INM-9) and Institute for Advanced Simulations (IAS-5), Forschungszentrum J\u00fclich, 52425 J\u00fclich, Germany."}, {"Identifier": [], "Affiliation": "Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen, 52062 Aachen, Germany."}], "LastName": "Albani", "ForeName": "Simone", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biomedicine, Institute for Neuroscience and Medicine (INM-9) and Institute for Advanced Simulations (IAS-5), Forschungszentrum J\u00fclich, 52425 J\u00fclich, Germany."}, {"Identifier": [], "Affiliation": "Faculty of Mathematics, Computer Science and Natural Sciences, RWTH Aachen, 52062 Aachen, Germany."}], "LastName": "Philipp", "ForeName": "Benjamin Joseph", "Initials": "BJ"}, {"Identifier": ["0000-0003-0200-1712"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Bioinorganic Chemistry, Department of Pharmacy and Biotechnology, University of Bologna, 40127 Bologna, Italy."}], "LastName": "Musiani", "ForeName": "Francesco", "Initials": "F"}, {"Identifier": ["0000-0002-3939-5172"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, Via Mangiagalli, 25, I-20133 Milano, Italy."}], "LastName": "Vistoli", "ForeName": "Giulio", "Initials": "G"}, {"Identifier": ["0000-0002-2032-4630"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Biomedicine, Institute for Neuroscience and Medicine (INM-9) and Institute for Advanced Simulations (IAS-5), Forschungszentrum J\u00fclich, 52425 J\u00fclich, Germany."}, {"Identifier": [], "Affiliation": "J\u00fclich Supercomputing Center (JSC), Forschungszentrum J\u00fclich, 52425 J\u00fclich, Germany."}, {"Identifier": [], "Affiliation": "Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation University Hospital Aachen, RWTH Aachen University, Pauwelsstra\u00dfe 30, 52074 Aachen, Germany."}], "LastName": "Rossetti", "ForeName": "Giulia", "Initials": "G"}, {"Identifier": ["0000-0001-6830-2695"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Domp\u00e9 Farmaceutici SpA, Via Campo di Pile, 67100 L'Aquila, Italy."}], "LastName": "Beccari", "ForeName": "Andrea Rosario", "Initials": "AR"}, {"Identifier": ["0000-0001-5916-2029"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dipartimento di Scienze Farmaceutiche, Universit\u00e0 degli Studi di Milano, Via Mangiagalli, 25, I-20133 Milano, Italy."}], "LastName": "Pedretti", "ForeName": "Alessandro", "Initials": "A"}], "GrantList": [{"GrantID": "101003551", "Agency": "Horizon 2020", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Peptide Hydrolases"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like protease, SARS coronavirus"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["virology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Repositioning"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": ["methods"], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Peptide Hydrolases"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": ["enzymology"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470\u2013473. doi: 10.1016/S0140-6736(20)30185-9.", "ArticleIdList": ["10.1016/S0140-6736(20)30185-9", "PMC7135038", "31986257"]}, {"Citation": "Li J., Huang D.Q., Zou B., Yang H., Hui W.Z., Rui F., Yee N.T.S., Liu C., Nerurkar S.N., Kai J.C.Y., et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics; risk factors; and outcomes. J. Med. Virol. 2020 doi: 10.1002/jmv.26424. online ahead of print.", "ArticleIdList": ["10.1002/jmv.26424", "PMC7436673", "32790106"]}, {"Citation": "Khailany R.A., Safdar M., Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682. doi: 10.1016/j.genrep.2020.100682.", "ArticleIdList": ["10.1016/j.genrep.2020.100682", "PMC7161481", "32300673"]}, {"Citation": "Michel C.J., Mayer C., Poch O., Thompson J.D. Characterization of accessory genes in coronavirus genomes. Virol. J. 2020;17:131. doi: 10.1186/s12985-020-01402-1.", "ArticleIdList": ["10.1186/s12985-020-01402-1", "PMC7450977", "32854725"]}, {"Citation": "Chellapandi P., Saranya S. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Med. Chem. Res. 2020;29:1777\u20131791. doi: 10.1007/s00044-020-02610-8.", "ArticleIdList": ["10.1007/s00044-020-02610-8", "PMC7394272", "32837137"]}, {"Citation": "Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens. 2020;9:186. doi: 10.3390/pathogens9030186.", "ArticleIdList": ["10.3390/pathogens9030186", "PMC7157630", "32143502"]}, {"Citation": "Shyr Z.A., Gorshkov K., Chen C.Z., Zheng W. Drug discovery strategies for SARS-CoV-2. J. Pharmacol. Exp. Ther. 2020;375:127\u2013138. doi: 10.1124/jpet.120.000123.", "ArticleIdList": ["10.1124/jpet.120.000123", "PMC7569306", "32723801"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., et al. Structure of mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Chuck C.P., Chow H.F., Wan D.C., Wong K.B. Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses. PLoS ONE. 2011;6:e27228. doi: 10.1371/journal.pone.0027228.", "ArticleIdList": ["10.1371/journal.pone.0027228", "PMC3206940", "22073294"]}, {"Citation": "Li Q., Kang C. Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease. Microorganisms. 2020;8:1250. doi: 10.3390/microorganisms8081250.", "ArticleIdList": ["10.3390/microorganisms8081250", "PMC7463875", "32824639"]}, {"Citation": "Gimeno A., Mestres-Truyol J., Ojeda-Montes M.J., Macip G., Saldivar-Espinoza B., Cereto-Massagu\u00e9 A., Pujadas G., Garcia-Vallv\u00e9 S. Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. Int. J. Mol. Sci. 2020;21:3793. doi: 10.3390/ijms21113793.", "ArticleIdList": ["10.3390/ijms21113793", "PMC7312484", "32471205"]}, {"Citation": "Elmezayen A.D., Al-Obaidi A., \u015eahin A.T., Yelek\u00e7i K. Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J. Biomol. Struct. Dyn. 2020;26:1\u201313. doi: 10.1080/07391102.2020.1758791.", "ArticleIdList": ["10.1080/07391102.2020.1758791", "PMC7189413", "32306862"]}, {"Citation": "Meyer-Almes F.J. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Comput. Biol. Chem. 2020;88:107351. doi: 10.1016/j.compbiolchem.2020.107351.", "ArticleIdList": ["10.1016/j.compbiolchem.2020.107351", "PMC7832737", "32769050"]}, {"Citation": "Olubiyi O.O., Olagunju M., Keutmann M., Loschwitz J., Strodel B. High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2. Molecules. 2020;25:3193. doi: 10.3390/molecules25143193.", "ArticleIdList": ["10.3390/molecules25143193", "PMC7396980", "32668701"]}, {"Citation": "Gao L.Q., Xu J., Chen S.D. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking. Chin. J. Integr. Med. 2020;26:527\u2013532. doi: 10.1007/s11655-020-3476-x.", "ArticleIdList": ["10.1007/s11655-020-3476-x", "PMC7338104", "32632717"]}, {"Citation": "Macchiagodena M., Pagliai M., Procacci P. Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling. Chem. Phys. Lett. 2020;750:137489. doi: 10.1016/j.cplett.2020.137489.", "ArticleIdList": ["10.1016/j.cplett.2020.137489", "PMC7165110", "32313296"]}, {"Citation": "Vistoli G., Mazzolari A., Testa B., Pedretti A. Binding Space Concept: A New Approach To Enhance the Reliability of Docking Scores and Its Application to Predicting Butyrylcholinesterase Hydrolytic Activity. J. Chem. Inf. Model. 2017;57:1691\u20131702. doi: 10.1021/acs.jcim.7b00121.", "ArticleIdList": ["10.1021/acs.jcim.7b00121", "28633528"]}, {"Citation": "Vistoli G., Pedretti A., Testa B. Assessing drug-likeness--what are we missing? Drug Discov. Today. 2008;13:285\u2013294. doi: 10.1016/j.drudis.2007.11.007.", "ArticleIdList": ["10.1016/j.drudis.2007.11.007", "18405840"]}, {"Citation": "Mazzolari A., Gervasoni S., Pedretti A., Fumagalli L., Matucci R., Vistoli G. Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays. Int. J. Mol. Sci. 2020;21:5961. doi: 10.3390/ijms21175961.", "ArticleIdList": ["10.3390/ijms21175961", "PMC7503225", "32825082"]}, {"Citation": "Mazzolari A., Vistoli G., Testa B., Pedretti A. Prediction of the Formation of Reactive Metabolites by A Novel Classifier Approach Based on Enrichment Factor Optimization (EFO) as Implemented in the VEGA Program. Molecules. 2018;23:2955. doi: 10.3390/molecules23112955.", "ArticleIdList": ["10.3390/molecules23112955", "PMC6278469", "30428514"]}, {"Citation": "Pedretti A., Mazzolari A., Gervasoni S., Vistoli G. Rescoring and Linearly Combining: A Highly Effective Consensus Strategy for Virtual Screening Campaigns. Int. J. Mol. Sci. 2019;20:2060. doi: 10.3390/ijms20092060.", "ArticleIdList": ["10.3390/ijms20092060", "PMC6540224", "31027337"]}, {"Citation": "Talarico C., Gervasoni S., Manelfi C., Pedretti A., Vistoli G., Beccari A.R. Combining Molecular Dynamics and Docking Simulations to Develop Targeted Protocols for Performing Optimized Virtual Screening Campaigns on The hTRPM8 Channel. Int. J. Mol. Sci. 2020;21:2265. doi: 10.3390/ijms21072265.", "ArticleIdList": ["10.3390/ijms21072265", "PMC7177470", "32218173"]}, {"Citation": "Wang R., Lai L., Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J. Comput.-Aided Mol. Des. 2002;16:11\u221226. doi: 10.1023/A:1016357811882.", "ArticleIdList": ["10.1023/A:1016357811882", "12197663"]}, {"Citation": "Korb O., St\u00fctzle T., Exner T.E. Empirical scoring functions for advanced protein-ligand docking with PLANTS. J. Chem. Inf. Model. 2009;49:84\u201396. doi: 10.1021/ci800298z.", "ArticleIdList": ["10.1021/ci800298z", "19125657"]}, {"Citation": "Vistoli G., Pedretti A., Mazzolari A., Testa B. In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations. Bioorg. Med. Chem. 2010;18:320\u2013329. doi: 10.1016/j.bmc.2009.10.052.", "ArticleIdList": ["10.1016/j.bmc.2009.10.052", "19932971"]}, {"Citation": "Pedretti A., Mazzolari A., Gervasoni S., Fumagalli L., Vistoli G. The VEGA suite of programs: A versatile platform for cheminformatics and drug design projects. Bioinformatics. 2020 doi: 10.1093/bioinformatics/btaa774. online ahead of print.", "ArticleIdList": ["10.1093/bioinformatics/btaa774", "33289523"]}, {"Citation": "Sastry G.M., Adzhigirey M., Day T., Annabhimoju R., Sherman W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 2013;27:221\u2013234. doi: 10.1007/s10822-013-9644-8.", "ArticleIdList": ["10.1007/s10822-013-9644-8", "23579614"]}, {"Citation": "Friesner R.A., Murphy R.B., Repasky M.P., Frye L.L., Greenwood J.R., Halgren T.A., Sanschagrin P.C., Mainz D.T. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 2006;49:6177\u20136196. doi: 10.1021/jm051256o.", "ArticleIdList": ["10.1021/jm051256o", "17034125"]}, {"Citation": "Yang S., Chen S.J., Hsu M.F., Wu J.D., Tseng C.T., Liu Y.F., Chen H.C., Kuo C.W., Wu C.S., Chang L.W., et al. Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J. Med. Chem. 2006;49:4971\u20134980. doi: 10.1021/jm0603926.", "ArticleIdList": ["10.1021/jm0603926", "16884309"]}, {"Citation": "Xie X., Muruato A.E., Zhang X., Lokugamage K.G., Fontes-Garfias C.R., Zou J., Liu J., Ren P., Balakrishnan M., Cihlar T., et al. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat. Commun. 2020;11:5214. doi: 10.1038/s41467-020-19055-7.", "ArticleIdList": ["10.1038/s41467-020-19055-7", "PMC7567097", "33060595"]}, {"Citation": "Chiou W.C., Hsu M.S., Chen Y.T., Yang J.M., Tsay Y.G., Huang H.C., Huang C. Repurposing existing drugs: Identification of SARS-CoV-2 3C-like protease inhibitors. J. Enzyme Inhib. Med. Chem. 2021;36:147\u2013153. doi: 10.1080/14756366.2020.1850710.", "ArticleIdList": ["10.1080/14756366.2020.1850710", "PMC7808739", "33430659"]}, {"Citation": "Jan J.T., Cheng T.R., Juang Y.P., Ma H.H., Wu Y.T., Yang W.B., Cheng C.W., Chen X., Chou T.H., Shie J.J., et al. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proc. Natl. Acad. Sci. USA. 2021;118:e2021579118. doi: 10.1073/pnas.2021579118.", "ArticleIdList": ["10.1073/pnas.2021579118", "PMC7865145", "33452205"]}, {"Citation": "Gupta A., Rani C., Pant P., Vijayan V., Vikram N., Kaur P., Singh T.P., Sharma S., Sharma P. Structure-Based Virtual Screening and Biochemical Validation to Discover a Potential Inhibitor of the SARS-CoV-2 Main Protease. ACS Omega. 2020;5:33151\u201333161. doi: 10.1021/acsomega.0c04808.", "ArticleIdList": ["10.1021/acsomega.0c04808", "PMC7754785", "33398250"]}, {"Citation": "Zhu Y., Xie D.Y. Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2. Front. Plant. Sci. 2020;11:601316. doi: 10.3389/fpls.2020.601316.", "ArticleIdList": ["10.3389/fpls.2020.601316", "PMC7733993", "33329667"]}, {"Citation": "Greenwood J.R., Calkins D., Sullivan A.P., Shelley J.C. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J. Comput. Aided Mol. Des. 2010;24:591\u2013604. doi: 10.1007/s10822-010-9349-1.", "ArticleIdList": ["10.1007/s10822-010-9349-1", "20354892"]}, {"Citation": "Harder E., Damm W., Maple J., Wu C., Reboul M., Xiang J.Y., Wang L., Lupyan D., Dahlgren M.K., Knight J.L., et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. J. Chem. Theory Comput. 2016;12:281\u2013296. doi: 10.1021/acs.jctc.5b00864.", "ArticleIdList": ["10.1021/acs.jctc.5b00864", "26584231"]}, {"Citation": "Gervasoni S., Vistoli G., Talarico C., Manelfi C., Beccari A.R., Studer G., Tauriello G., Waterhouse A.M., Schwede T., Pedretti A. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0. Int. J. Mol. Sci. 2020;21:5152. doi: 10.3390/ijms21145152.", "ArticleIdList": ["10.3390/ijms21145152", "PMC7403965", "32708196"]}, {"Citation": "Phillips J.C., Hardy D.J., Maia J.D.C., Stone J.E., Ribeiro J.V., Bernardi R.C., Buch R., Fiorin G., Henin J., Jiang W., et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 2020;153:044130. doi: 10.1063/5.0014475.", "ArticleIdList": ["10.1063/5.0014475", "PMC7395834", "32752662"]}, {"Citation": "Stewart J.J. Optimization of parameters for semiempirical methods VI: More modifications to the NDDO approximations and re-optimization of parameters. J. Mol. Model. 2013;19:1\u201332. doi: 10.1007/s00894-012-1667-x.", "ArticleIdList": ["10.1007/s00894-012-1667-x", "PMC3536963", "23187683"]}, {"Citation": "Pedretti A., Mazzolari A., Vistoli G. WarpEngine, a Flexible Platform for Distributed Computing Implemented in the VEGA Program and Specially Targeted for Virtual Screening Studies. J. Chem. Inf. Model. 2018;58:1154\u20131160. doi: 10.1021/acs.jcim.8b00086.", "ArticleIdList": ["10.1021/acs.jcim.8b00086", "29746777"]}, {"Citation": "Beccari A.R., Cavazzoni C., Beato C., Costantino G. LiGen: A high performance workflow for chemistry driven de novo design. J. Chem. Inf. Model. 2013;53:1518\u20131527. doi: 10.1021/ci400078g.", "ArticleIdList": ["10.1021/ci400078g", "23617275"]}, {"Citation": "Beato C., Beccari A.R., Cavazzoni C., Lorenzi S., Costantino G. Use of experimental design to optimize docking performance: The case of LiGenDock.; the docking module of LiGen.; a new de novo design program. J. Chem. Inf. Model. 2013;53:1503\u20131517. doi: 10.1021/ci400079k.", "ArticleIdList": ["10.1021/ci400079k", "23590204"]}, {"Citation": "Hawkins P.C., Skillman A.G., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model. 2010;50:572\u2013584. doi: 10.1021/ci100031x.", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "McGann M. FRED pose prediction and virtual screening accuracy. J. Chem. Inf. Model. 2011;51:578\u2013596. doi: 10.1021/ci100436p.", "ArticleIdList": ["10.1021/ci100436p", "21323318"]}, {"Citation": "Halgren T.A., Murphy R.B., Friesner R.A., Beard H.S., Frye L.L., Pollard W.T., Banks J.L. Glide: A new approach for rapid.; accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 2004;47:1750\u20131759. doi: 10.1021/jm030644s.", "ArticleIdList": ["10.1021/jm030644s", "15027866"]}, {"Citation": "Pedretti A., Granito C., Mazzolari A., Vistoli G. Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+.; a Versatile Rescoring Tool of the VEGA ZZ Program. Mol. Inform. 2016;35:424\u2013433. doi: 10.1002/minf.201501030.", "ArticleIdList": ["10.1002/minf.201501030", "27546046"]}, {"Citation": "Baker N.A., Sept D., Joseph S., Holst M.J., McCammon J.A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA. 2001;98:10037\u201310041. doi: 10.1073/pnas.181342398.", "ArticleIdList": ["10.1073/pnas.181342398", "PMC56910", "11517324"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "13"}, {"Year": "2021", "Month": "1", "Day": "20"}, {"Year": "2021", "Month": "1", "Day": "26"}, {"Year": "2021", "Month": "2", "Day": "9", "Hour": "1", "Minute": "3"}, {"Year": "2021", "Month": "2", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["33557115", "PMC7913849", "10.3390/molecules26040797", "molecules26040797"]}}], "PubmedBookArticle": []}